Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Neuraxis, INC Director's Dealing 2026

Feb 27, 2026

34793_dirs_2026-02-26_fa0c7d69-4592-4240-82e9-79f1919cc61a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuraxis, INC (NRXS)
CIK: 0001933567
Period of Report: 2026-01-22

Reporting Person: Keyser Jane Elizabeth (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-01-22 Common Stock A 21598 $4.63 Acquired 46335 Direct

Footnotes

F1: These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.